YAP1::MAML2 fusions in poromatosis: A report of two patients.
Yasuhiro MitsuiKohei OgawaKeisuke GotoTomomi FujiiYuki Nakamura-NishimuraKumi MashibaHideo AsadaPublished in: Journal of cutaneous pathology (2023)
Poromatosis is a rare condition characterized by the development of multiple poromas, mainly reported in patients with a history of malignancy. Recently, frequent YAP1::MAML2 and YAP1::NUTM1 fusions have been described in poromas and porocarcinomas. To date, the molecular features of poromatosis have been investigated in one patient only, wherein the poromas harbored YAP1::MAML2 fusions. Herein, we present two additional cases of poromatosis with YAP1::MAML2 fusions. Case 1: An 81-year-old woman presented with nine papules on the scalp, trunk, and extremities persisting for a year. She had a history of breast cancer, with no information on the treatment. Seven papules were excised. Case 2: A 65-year-old woman presented with 21 lesions on her trunk and lower extremities persisting for two years. She was diagnosed with breast cancer 11 years prior and underwent partial mastectomy, radiotherapy, chemotherapy, and endocrine therapy. Four lesions were excised. All 11 lesions in both patients were histopathologically similar: anastomosing cords and strands extending from the epidermis and poroid and cuticular cell proliferation with interspersed small ducts. The tumors showed diffuse nuclear expression of YAP1 N-terminus and loss of YAP1 C-terminus expression. No lesions showed NUT immunopositivity. Sanger sequencing identified YAP1::MAML2 fusions in the poromas of both patients. This article is protected by copyright. All rights reserved.
Keyphrases
- end stage renal disease
- ejection fraction
- cell proliferation
- newly diagnosed
- poor prognosis
- prognostic factors
- stem cells
- early stage
- healthcare
- squamous cell carcinoma
- radiation therapy
- young adults
- patient reported outcomes
- signaling pathway
- mass spectrometry
- long non coding rna
- locally advanced
- low grade
- single molecule
- smoking cessation
- soft tissue
- binding protein
- bone marrow
- lower limb
- atomic force microscopy
- health information
- chemotherapy induced